Medicare Enrolled
Dr. Omar Khan, M.D
Urology Physician · Toledo, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Omar Khan is an urology physician in Toledo, OH, with 15 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 2,345 Medicare services across 1,888 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $5,553 from 43 pharmaceutical and/or device companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 24% volume in OH
$5,553 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,345
Medicare services
Top 24% in OH for urology physician
1,888
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~156 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
623 | $81 | $195 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
242 | $58 | $139 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
230 | $128 | $361 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
222 | $110 | $252 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 162 | $136 | $527 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
143 | $7 | $35 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
116 | $2 | $7 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
67 | $113 | $390 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
64 | $345 | $826 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
60 | $527 | $3,156 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
48 | $176 | $420 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
48 | $98 | $324 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
41 | $122 | $357 |
| Injection, tobramycin sulfate, up to 80 mg | 33 | $2 | $12 |
| Simple change of bladder tube | 30 | $67 | $170 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $71 | $198 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
27 | $25 | $54 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $124 | $267 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
22 | $19 | $40 |
| Cystourethroscopy with ureteroscopy or pyeloscopy A diagnostic procedure using an endoscope to examine the bladder, urethra, and ureter or kidney. |
18 | $223 | $560 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
16 | $199 | $510 |
| Injection, garamycin, gentamicin, up to 80 mg | 15 | $2 | $12 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
14 | $3 | $6 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
13 | $42 | $84 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
12 | $254 | $1,261 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
12 | $116 | $288 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
12 | $919 | $2,772 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.3% high complexity
14.3% medium
78.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,553
Total received (2018-2024)
Avg $793/year across 7 years
Top 29% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
228
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,181 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$372 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$738
2023
$948
2022
$955
2021
$936
2020
$392
2019
$248
2018
$1,336
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$262
AstraZeneca Pharmaceuticals LP
$141
Sumitomo Pharma America, Inc.
$81
Boston Scientific Corporation
$81
Medtronic, Inc.
$69
Bayer Healthcare Pharmaceuticals Inc.
$29
Antares Pharma, Inc.
$21
Astellas Pharma US Inc
$20
PROGENICS PHARMACEUTICALS, INC.
$17
C. R. Bard, Inc. & Subsidiaries
$17
Top 3 companies account for 65.6% of 2024 payments
All-time payments by company (2018-2024) ›
BOSTON SCIENTIFIC CORPORATION
$1,086
Astellas Pharma US Inc
$849
Endo Pharmaceuticals Inc.
$300
Myovant Sciences Inc.
$277
PROCEPT BioRobotics Corporation
$262
Janssen Biotech, Inc.
$245
Medtronic, Inc.
$220
Rochester Medical Corporation
$214
AstraZeneca Pharmaceuticals LP
$196
Intuitive Surgical, Inc.
$163
PFIZER INC.
$154
Antares Pharma, Inc.
$142
Blue Earth Diagnostics Limited
$140
Sumitomo Pharma America, Inc.
$120
C. R. Bard, Inc. & Subsidiaries
$120
Dendreon Pharmaceuticals LLC
$97
UROVANT SCIENCES INC
$96
Boston Scientific Corporation
$94
TOLMAR Pharmaceuticals, Inc.
$75
Teleflex LLC
$67
ABBVIE INC.
$56
Travere Therapeutics, Inc.
$52
Axonics, Inc.
$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Bayer Healthcare Pharmaceuticals Inc.
$44
Olympus America Inc.
$35
MEDIVATION FIELD SOLUTIONS LLC
$33
Amgen Inc.
$31
Progenics Pharmaceuticals, Inc.
$31
Smith+Nephew, Inc.
$30
Caldera Medical, Inc
$30
Coloplast Corp
$27
ConvaTec Inc.
$26
Integra LifeSciences Corporation
$24
PROGENICS PHARMACEUTICALS, INC.
$17
Tolmar, Inc.
$16
Supernus Pharmaceuticals, Inc.
$16
Ferring Pharmaceuticals Inc.
$15
Kowa Pharmaceuticals America, Inc.
$14
Avanos Medical
$13
Allergan Inc.
$12
Allergan, Inc.
$11
Myriad Genetic Laboratories, Inc.
$11
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
AMS · AQUABEAM SYSTEM · AVEED · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · Da Vinci Surgical System · Desara · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENTLECATH · INTERSTIM · Integra · LITHOVUE · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ON-Q PUMP AND ACCESSORIES · ORGOVYX · PROVENGE · PYLARIFY · Prolaris · Prolia · SOLYX · STRAVIX · SYMPHION · Seglentis · SpeediCath · TOVIAZ · Thiola · UROLIFT · UroLift System · VESICARE · XGEVA · XIAFLEX · XIFAXAN · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
37
Per 100K population
8.6
County median income
$60,095
Nearest hospital
ASSURANCE HEALTH TOLEDO LLC
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 24% in OH), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khan performed 623 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $5,553 from 43 companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other urology physicians in Toledo?
Dr. Khan's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Toledo
Browse urology physicians in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology